Impacts of Antimicrobial Resistance on Cancer Care

What You Will Learn
People receiving treatment for cancer are at a higher risk for infections. The growing global public health threat of antimicrobial resistance can make these infections harder — if not impossible — to treat.

Join CDC and a panel of experts to learn about:

• How antimicrobial resistance can be a major obstacle for cancer care and cancer survival.
• The importance of infection prevention and control efforts in health care to limit cancer patient exposure to antimicrobial-resistant germs.
• The connection between the health of the microbiome (the naturally occurring germs on and in our bodies) and the effectiveness of some cancer therapies.
• How U.S. and international organizations are strengthening infection prevention efforts and combating antimicrobial resistance as core components of cancer care.

Join us to learn more about CDC’s antimicrobial resistance investments and how CDC and partners are implementing this work.